Delaying VS Ending Age-Related Diseases - João Pedro de Magalhães  -  Lifespan.io @LifespanIO
Delaying VS Ending Age-Related Diseases - João Pedro de Magalhães  -  Lifespan.io  @LifespanIO
Uploaded December 2021 | Updated November 2026, 5 days ago
Delaying VS Ending Age-Related DiseasesIn - João Pedro de Magalhães presentation at Lifespan.io’s 2021 EARD conference, Professor João Pedro de Magalhães compares and contrasts delaying vs. ending age-related diseases.

FOLLOW US
▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀
lifespan.io
facebook.com/lifespanio
instagram.com/lifespan.io

DESCRIPTION
▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀
Professor João Pedro de Magalhães graduated in Microbiology in 1999 from the Escola Superior de Biotecnologia in his hometown of Porto, Portugal, and in 2004 obtained a PhD in Biological Sciences from the University of Namur in Belgium. Following further training in genetics at Harvard Medical School, in 2008 Prof de Magalhaes joined the University of Liverpool in the UK and established the Integrative Genomics of Ageing group. His research on genetics, ageing and longevity has been widely featured in scientific magazines and he has published over 100 scientific papers. Prof de Magalhaes is a world-leader in big data and computational analyses. In addition, he has a long term interest in technological trends and their future impact on society. His work on predicting how technology will shape the human condition has been published in magazines such as Futures and The Futurist, and in newspapers like The Independent. Prof de Magalhaes has given over 100 invited talks in international conferences, and in many academic institutions and companies (e.g., Google’s Calico and Allianz). He also makes regular media appearances (BBC, CNN, the Washington Post, the Financial Times and many others). He is Chief Scientific Officer of Centaura, an ambitious biotech company in Switzerland focused on healthy ageing , and founded his own his company Magellan Science Ltd.

The annual Ending Age-Related Diseases (EARD) conference by Lifespan.io brings together longevity thought leaders together to exchange research reports, inspire and get inspired with new ideas, find collaborators, supporters, and mentors.


HOW CAN YOU SUPPORT US?
▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀
Lifespan.io, a 501(c)(3) nonprofit organization.
► Support us with monthly donations by becoming a Lifespan Hero:
lifespan.io/hero
► Subscribe: youtube.com/user/LifespanIO
► Learn more, and help us: lifespan.io

#JoãoPedrodeMagalhães #EndingAgeRelatedDiseases #Reversinghumanaging #RejuvenationBiotechnologies #Longevity #ReversingCellAge
#JoãoPedrodeMagalhães #EndingAgeRelatedDiseases #Reversinghumanaging
Delaying VS Ending Age-Related Diseases - João Pedro de Magalhães  -  Lifespan.ioKey Trends In Rejuvenation Medicine - Fiona Miller - EARD 2022Longevity Storytelling: How Media Shapes Progress (EARD 2023)Arunan Skandarajah of ARPA-H presents ARPA-H: Program Manager 101 at EARD 2023Dr. Yu Xuan Lu Describes How Rapamycin Is Used for LongevityHands-On Crypto Wallet Workshop by VitaDAO and Weavechain at EARD 2023The Future of Philanthropy: Dynamic NFTsAffordable Gene Therapies Are Coming! - George Church at EARDReversing Cell Age, Suppressing Cell Identity, Can Ontogeny Be Reversed? - Jacob Kimmel Lifespan.IODAO Innovators Talk About Biomarker Usage and the Future of Decentralized ScienceRejuvenation Roundup Podcast - December 2021The Best Epigenetic Aging Clocks with Dr. Varun Dwaraka
Lifespan Research Institute |

Delaying VS Ending Age-Related Diseases - João Pedro de Magalhães - Lifespan.io

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER